Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve.

Robert A DeSimoneVictoria A CostaKathleen KaneJorge L SepulvedaGrant B EllsworthRoy M GulickJason ZuckerMagdalena E SobieszcykJoseph SchwartzMelissa M Cushing

Published in: Transfusion (2020)

There is a need to closely monitor the blood product inventory and demand throughout the COVID-19 pandemic as patients' transfusion needs may increase over time. Daily or weekly trending of patients' clinical status and laboratory values may assist blood banks in inventory management.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
sars cov
patient reported outcomes
acute kidney injury
psychometric properties